GDF 15 - A Novel Biomarker in the Offing for Heart Failure |
| |
Authors: | Melvin George Amrita Jena Varsha Srivatsan Rajaram Muthukumar VE Dhandapani |
| |
Institution: | SRM Medical College Hospital & Research Centre – Cardiology, Chennai, Tamil Nadu, India |
| |
Abstract: | Background:Several diagnostic and prognostic biomarkers are being explored in heart failure.
GDF-15 belongs to the transforming growth factor β (TGF-β) cytokine family that is highly up
regulated in inflammatory conditions. We undertook this systematic review to summarize the current
evidence on the utility of GDF-15 as a biomarker in heart failure.Design and Methods:Multiple electronic databases for studies that reported the association between
GDF- 15 and heart failure were searched using different electronic databases such as MEDLINE, Science
Direct, Springer Link, Scopus, Cochrane Reviews, and Google Scholar using pre-defined inclusion-
exclusion criteria.Results:Twenty one original studies were identified that included data from 20,920 study participants. GDF 15 was found
to be a strong prognosticator of all-cause mortality in heart failure patients. Several studies found the benefit of using
GDF-15 as a component of a multi-biomarker strategy in prognosticating patients with heart failure.Conclusion:More studies are warranted to elucidate the molecular pathways involving GDF-15 and to see how knowledge
about GDF-15 can be used to make therapeutic decisions in the clinic. |
| |
Keywords: | All-cause mortality cardiac biomarker GDF -15 heart failure novel biomarker prognosis |
|
|